PIRAHENZ 800MG TABLET 10'S

PIRAHENZ 800MG TABLET belongs to a group of medicines called GABA analogues used to treat myoclonus (a movement disorder). Additionally, PIRAHENZ 800MG TABLET is also used to treat memory disorders, vertigo, and dyslexia (learning disorder) in children above 8 years. Myoclonus is a movement disorder that causes uncontrollable twitching and jerky movements of the arms and legs.

PIRAHENZ 800MG TABLET contains 'Piracetam', which acts on the brain and nervous system, thereby protecting against oxygen deprivation. It also improves the activity of a chemical messenger called acetylcholine, which helps in communication between brain cells.

You are advised to take PIRAHENZ 800MG TABLET as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience specific common side effects, such as headache, sleepiness, stomach pain, diarrhoea, weakness, nausea, and restlessness. You are advised to talk to your doctor if the side effects persist or worsen.

Please do not stop taking PIRAHENZ 800MG TABLET without consulting your doctor. Consult your doctor if you are pregnant or breastfeeding. Avoid driving or operating machinery, as PIRAHENZ 800MG TABLET can cause drowsiness, sleepiness, and shakiness. Avoid consuming alcohol along with PIRAHENZ 800MG TABLET as it could lead to increased sleepiness. PIRAHENZ 800MG TABLET is not recommended for children below 8 years as the safety and effectiveness have not been established.

PIRAHENZ 800MG TABLET is used in the treatment of myoclonus (a movement disorder), memory disorders, vertigo, and dyslexia (a learning disorder). The detailed uses of PIRAHENZ 800MG TABLET are as follows:

• Movement Disorders: PIRAHENZ 800MG TABLET can help lessen involuntary movements in people with certain movement disorders, such as dystonia.
• Mood Stabilisation: Off-label use may occasionally be employed to help people with anxiety disorders or associated symptoms manage their mood and lessen their worry.
• Cognitive Enhancement: In high-demand scenarios, such as studying or performing strenuous work activities, some people utilise PIRAHENZ 800MG TABLET to enhance cognitive function, including memory, focus, and overall mental performance.
• Treatment of Vertigo: PIRAHENZ 800MG TABLET is mainly used to treat vertigo, which is a disorder that can make you feel lightheaded and like you're spinning.

• Take PIRAHENZ 800MG TABLET with or without food, or as advised by a doctor.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Swallow the medicine as a whole with a glass of water.
• Do not crush, break, or chew it.

PIRAHENZ 800MG TABLET is a nootropic drug which belongs to a group of medicines called GABA analogues. PIRAHENZ 800MG TABLET is used to treat myoclonus (a movement disorder). Additionally, PIRAHENZ 800MG TABLET is also used for the symptomatic treatment of cognitive and memory disorders caused by organic disorders, vertigo, and dyslexia (learning disorder) in children above 8 years. PIRAHENZ 800MG TABLET acts on the brain and nervous system, thereby protecting against a shortage of oxygen. It also improves the activity of a chemical messenger called acetylcholine, which helps in communication between brain cells. PIRAHENZ 800MG TABLET may also act on the N-methyl-D-aspartate (NMDA) receptors that are involved in the transmission of nerve signals, which play an important role in memory.

Do not take PIRAHENZ 800MG TABLET if you are allergic to any of its components; if you have/had a serious kidney problem, Huntington's disease or brain haemorrhage. Inform your doctor if you have kidney dysfunction or bleeding problems. Consult your doctor if you are pregnant, planning for pregnancy or breastfeeding. Avoid driving or operating machinery as PIRAHENZ 800MG TABLET may cause drowsiness, sleepiness and shakiness. Avoid consuming alcohol along with PIRAHENZ 800MG TABLET as it could lead to increased sleepiness. PIRAHENZ 800MG TABLET is not recommended for children below 8 years as safety and effectiveness have not been established.